EUVIMEDEUVIMED entdecken
Fallbericht

Utility of p53 immunohistochemistry as a surrogate for sequencing in myeloid neoplasms: A tale of caution

Karen A Nahmod iD, Koji Sasaki iD, Chi Young Ok iD, Sanam Loghavi iD

American Journal of Hematology · 2024

DOI: 10.1002/ajh.26970 ↗

Kurz gefasst

Fallbericht in der Zeitschrift American Journal of Hematology, 2024. Verfasst von Karen A Nahmod und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Hauptthemen laut MEDLINE: Myeloproliferative Disorders, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The authors declare no conflicts of interest. Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myeloproliferative DisordersNeoplasmsHumansTumor Suppressor Protein p53ImmunohistochemistryMutation

Substanzen

Tumor Suppressor Protein p53

Autor:innen und Institutionen

  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

ORCID-Profile: Karen A Nahmod, Koji Sasaki, Chi Young Ok, Sanam Loghavi

Zitieren

APA

Nahmod, K. A., Sasaki, K., Ok, C. Y., & Loghavi, S. (2024). Utility of p53 immunohistochemistry as a surrogate for sequencing in myeloid neoplasms: A tale of caution. American Journal of Hematology. https://doi.org/10.1002/ajh.26970

Vancouver

Nahmod KA, Sasaki K, Ok CY, Loghavi S. Utility of p53 immunohistochemistry as a surrogate for sequencing in myeloid neoplasms: A tale of caution. American Journal of Hematology. 2024. doi:10.1002/ajh.26970

BibTeX
@article{Nahmod2024,
  author = {Nahmod, Karen A and Sasaki, Koji and Ok, Chi Young and Loghavi, Sanam},
  title = {Utility of p53 immunohistochemistry as a surrogate for sequencing in myeloid neoplasms: A tale of caution},
  journal = {American Journal of Hematology},
  year = {2024},
  doi = {10.1002/ajh.26970}
}
Kostenlos starten →